VITI, INC.

Medtech · Private

Immunodiagnostic blood test detecting Mtb-reactive CD8+ T cells using clinically-validated peptide antigens to diagnose active tuberculosis in children under 5 years old

Grants
$975K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · A CD8+ T cell diagnostic to identify children with pulmonary tuberculosis$975,202
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
771MOSAIC LOFT——
772IRON HORSE DIAGNOSTICS, INC.——
773ETECT, INC.——
774VITI, INC.——
775OPTAVE DIAGNOSTICS LLC——
776Lalaith Astor Technical Consulting House, LLC——
777PhotoSonix Medical, Inc.—$410K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 2
  • Methods for Detecting A Mycobacterium Tuberculosis Infectionapplication
  • Methods For Detecting A Mycobacterium Tuberculosis Infectionapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.